Iq Eq Fund Management (Ireland) LTD Biogen Inc. Transaction History

Iq Eq Fund Management (Ireland) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$282.99 - $369.05 $237,145 - $309,263	-838 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$259.0 - $414.71 $59,570 - $95,383	-230 Reduced 21.54%	838 $290,000
Q1 2020 May 05, 2020	SELL	$268.85 - $341.04 $19,357 - $24,554	-72 Reduced 6.32%	1,068 $338,000
Q4 2019 Feb 06, 2020	SELL	$220.06 - $304.07 $41,811 - $57,773	-190 Reduced 14.29%	1,140 $338,000
Q2 2019 Jul 19, 2019	BUY	$219.29 - $241.72 $291,655 - $321,487	1,330 New	1,330 $311,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.